Physician

Anna Kazanskaya, M.D.

According to 2025 Medicare claims, Anna Kazanskaya, M.D. (NPI: 1487614814) practices geriatric medicine in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Westchester, NY. This provider's primary affiliated billing organization is LAWRENCE MEDICAL ASSOCIATES, PC (NPI: 1023257441; TIN: 264076297) and primary practice location at 10709-5545. Kazanskaya is affiliated with the NewYork Quality Care (ACO ID: A2571), participating under the MSSP model.

Kazanskaya's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 238 traditional Medicare patients, billed 1,058 HCPCS/CPT codes, and received $80,316 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 4,789 prescription claims across 352 beneficiaries totaling $374,851 in drug costs, led by Eliquis (Apixaban). DME data shows 11 claims. Open Payments data shows 3 records totaling $57. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and declined steadily, from $9,133 to $706.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	312	1,246	$96,536
2016	315	1,568	$110,420
2017	276	1,366	$99,172
2018	265	1,368	$88,071
2019	265	1,673	$99,841
2020	243	1,629	$97,980
2021	236	1,494	$100,363
2022	238	1,227	$84,186
2023	251	1,205	$92,365
2024	238	1,058	$80,316

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	318	9,576	$266,099
2016	310	9,130	$295,496
2017	304	8,352	$340,619
2018	304	8,220	$360,083
2019	286	8,823	$338,967
2020	254	7,945	$338,596
2021	257	7,379	$395,760
2022	260	6,536	$304,496
2023	315	4,634	$316,446
2024	352	4,789	$374,851

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	29	154	$3,270
2016	27	161	$3,056
2017	N/R	208	$6,707
2018	11	298	$5,780
2019	N/R	173	$5,180
2020	N/R	156	$2,708
2021	N/R	217	$3,910
2022	N/R	57	$927
2023	N/R	N/R	N/R
2024	N/R	11	$144

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	91	123	$156
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	91	131	$102
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	48	64	$79
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	62	73	$14
36415	Insertion of needle into vein for collection of blood sample	138	207	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	129	5,532	$109,004
Rybelsus	Semaglutide	17	990	$29,112
Januvia	Sitagliptin Phosphate	21	1,470	$27,084
Tradjenta	Linagliptin	24	336	$6,207
Entresto	Sacubitril/Valsartan	19	285	$6,131

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
K0001	Standard wheelchair	Y	N/R	11	$144

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$57	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anna Kazanskaya, M.D.?

Tedicare shows public-source Medicare data for Anna Kazanskaya, M.D. (NPI 1487614814), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anna Kazanskaya, M.D. have ACO affiliation data?

Anna Kazanskaya, M.D. is shown with ACO affiliation data for NewYork Quality Care (MSSP, ACO ID A2571).

What billing organization is linked to Anna Kazanskaya, M.D.?

Anna Kazanskaya, M.D. is linked to LAWRENCE MEDICAL ASSOCIATES, PC (billing NPI 1023257441) in the available physician profile data.

Does Anna Kazanskaya, M.D. have Open Payments data?

Anna Kazanskaya, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.